<DOC>
	<DOC>NCT00426478</DOC>
	<brief_summary>A double-blind, active-controlled, randomized trial to compare Valsartan plus Hydrochlorothiazide 80mg/12.5mg and Amlodipine 5 mg. Study design: 2 weeks washout, 8 weeks treatment period.</brief_summary>
	<brief_title>Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in Hypertensive Patients</brief_title>
	<detailed_description />
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Female or male patient with age ≧ 18 years old. Patient with mild to moderate uncomplicated essential hypertension, and the blood pressure not adequately controlled on existing antihypertensive treatment. Patient with sitting systolic blood pressure (sSBP)/ sitting diastolic blood pressure (sDBP) ≦ 180/110 mmHg at screening visit. For nondiabetic patient, sitting systolic blood pressure (sSBP) ≧ 140 mmHg or sitting diastolic blood pressure (sDBP) ≧ 90 mmHg at baseline visit; for diabetic patient, sitting systolic blood pressure (sSBP) ≧ 130 mmHg or sitting diastolic blood pressure (sDBP) ≧ 80 mmHg at baseline visit. Patient or his/her legally acceptable representative has signed and dated the informed consent form. Known or suspected secondary hypertension. sSBP &gt; 180 mmHg or sDBP &gt; 110 mmHg at baseline visit. Patients taking more than two antihypertensive medications at the screening visit. (Fixeddose combinations of two or more antihypertensive therapies will be counted as two or more antihypertensive medications.) Known NYHA functional class Chronic Heart Failure (CHF) III and IV. With a history of myocardial infarction, transient ischemic attack or cerebrovascular accident within the preceding 6 months, clinically significant valvular heart disease, or hepatic and/or renal dysfunction as defined by the following laboratory parameters SGPT (ALT) or SGOT (AST) &gt; two times upper the limit of normal range Serum creatinine &gt; 2.3 mg/dl or creatinine clearance &lt; 30 ml/min Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>AMPM, SBP, DBP, Valsartan plus Hydrochlorothiazide, Amlodipine, high blood pressure</keyword>
</DOC>